TALECRIS VISION
CORPORATE SITES
Talecris Canada
Talecris Europe
Talecris Corporate
View All
PRODUCT SITES
Alpha-1 Antitrypsin Deficiency
(Prolastin/Prolastina)
Immune Globulin Intravenous
Therapy
(IGIV) (Gamunex)
Antihemophilic Factor VIII
(Koāte-DVI)
Antithrombin III
(Thrombate III)
Human Albumin Products
(Plasbumin / Plasmanate)
Hyperimmune Globulin Therapy
(Hypermunes)
View All
PROGRAMS & SERVICES
Gamunex Direct
Prolastin Direct
Contract Manufacturing Services
Talecris Plasma Resources
View All
CONTACT TALECRIS
United States
Home
About Talecris US
Our Products
Our Services
Press Releases
Careers
Commitment to Patients
Product Information
Reimbursement Support
Product Overview
Delivery Services
Reimbursement Support
Search for Jobs
Benefits Information
Contact Information
Press Releases
Quick Facts
Corporate HQ Media Center
Talecris has issued a recall for HyperRHO™ S/D, Rh
0
(D) Immune Globulin (Human) (mini-dose) lot number 26N7XX1.
Talecris distributed the recalled lot only to customers in the United States.
Please find the details regarding this recall within the attached document below.
Recall Notice: Hyper
RHO
™ S/D Mini-Dose
Contact Talecris
Glossary
Site Map
General Conditions of Use
Privacy Statement
California Compliance
© 2008 Talecris Biotherapeutics
